Get Started
Lung Cancer Curricula
Step 1
Curriculum III
Curriculum II
These independent CME/CE activities are supported by an educational grant from

Curriculum II

Genentech BioOncology, OSI Oncology, and Pfizer Inc.

Curriculum I

Genentech BioOncology and OSI Oncology.
Curriculum I
These independent CME/CE activities are supported by educational grants from Genentech BioOncology

OSI Oncology



The Advanced Certificate Program in
Lung Cancer Management III
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Lung Cancer Virtual Tumor BoardPodcast Series (LC03.14) 1986 III Langer
Bradley
Donington
Dec 2010
Case Study: ALK Inhibition in Non–Small-Cell Lung CancerTx Reporter with Audio (LC03.13) 1980.03 III Herbst
Langer
Dec 2010
Case Study: Combined Modality Approach in Patients with Unresected Stage III NSCLC and Good Performance StatusTx Reporter with Audio (LC03.12) 1980.02 III Herbst
Gore
Dec 2010
Expert Insight Into: Novel Mutant-Selective EGFR Kinase Inhibitors Against EGFR T790M (Part 10 of Series)Article Review (LC03.11) 1979.10 III Miller Oct 2010
Expert Insight Into: A Dose Intensification Study of Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Inoperable Non-Small-Cell Lung Cancer (Part 9 of Series) Article Review (LC03.10) 1979.09 III Gore Oct 2010
Expert Insight Into: First-Line EGFR TKI Use in Patients with Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations (Part 8 of Series)Article Review (LC03.09) 1979.08 III Miller Sep 2010
Expert Insight Into: Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer (Part 7 of Series) Article Review (LC03.08) 1979.07 III Langer Jul 2010
Expert Insight Into: EGFR Tyrosine Kinase Inhibitor as Maintenance Therapy for Advanced NSCLC (Part 6 of Series)Article Review (LC03.07) 1979.06 III Herbst Jun 2010
Case Study: EGFR Mutation Testing in a Never-Smoker with Advanced Stage NSCLC Tx Reporter e-Newsletter (LC03.06) 1980 III Langer May 2010
Expert Insight Into: Maintenance Therapy Versus Placebo for NSCLC (Part 5 of Series)Article Review (LC03.05) 1979.05 III Langer Apr 2010
Expert Insight Into:
Radiotherapy plus Chemotherapy With or Without Surgical Resection for Stage III NSCLC (Part 4 of series)
Article Review (LC03.04) 1979.04
III Herbst Apr 2010
Expert Insight Into: Clinical Features and Outcome of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK (Part 3 of Series)Article Review (LC03.03) 1979.03 III Langer Mar 2010
Expert Insight Into: EGFR Tyrosine Kinase Inhibitor or Combination Chemotherapy in Advanced Pulmonary Adenocarcinoma (Part 2 of Series)Article Review (LC03.02) 1979.02 III Herbst Feb 2010
Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Part 1 of Series)Article Review (LC03.01) 1979.01 III Langer Feb 2010
Expert Insight Into: Induction Chemotherapy Followed By Concurrent Chemotherapy And Dose-Escalated Thoracic Conformal Radiotherapy In Stage III NSCLCArticle Review (LC02.17) 1871.12 II Gore Aug 2009
Case Study: NSCLC (Squamous Cell Carcinoma) in a Patient with COPDTx Reporter with Audio (LC02.16) 1872.04 II Herbst
Gore
Unger
Aug 2009
Expert Insight Into: Postoperative Radiation Therapy in Patients with Complete Resection and Stage I, II, or IIIA NSCLC Treated with Adjuvant ChemotherapyArticle Review (LC02.15) 1871.11 II Gore Jul 2009
Management of Stage III, N2 NSCLC: A Virtual Thoracic Oncology Tumor BoardWebcast (LC02.14) 1873 II Herbst
Langer
Gore
Shrager
Unger
Jun 2009
Expert Insight Into: Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients with Advanced Non-€“Small-Cell Lung Cancer and a Performance Status of 2Article Review (LC02.13) 1871.09 II Langer May 2009
Case Study: Small-Cell Lung CancerTx Reporter e-Newsletter (LC02.12) 1872.03 II Herbst
Gore
Apr 2009
Expert Insight Into: Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy After Resection for Lung CancerArticle Review (LC02.11) 1871.08 II Shrager Apr 2009
Expert Insight Into: Consolidation Therapy (Docetaxel) Stage III NSCLCArticle Review (LC02.10) 1871.07 II Langer Apr 2009
Expert Insight Into: Comparison of Two Antineoplastic/Platinum-based Combination Treatment Regimens in Extensive Small-Cell Lung CancerArticle Review (LC02.09) 1871.10 II Govindan Mar 2009
Case Study: Limited Multifocal Bronchioloalveolar Adenocarcinoma (BAC)Tx Reporter e-Newsletter (LC02.08) 1872.02 II Herbst
Shrager
Mar 2009
Expert Insight Into: Minimally Invasive Endoscopic Staging of Suspected Lung CancerArticle Review (LC02.07) 1871.05 II Unger Feb 2009
Expert Insight Into: Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization (FISH) Predicts Outcome in Non-Small-Cell Lung Cancer Patients Treated with Cetuximab and ChemotherapyArticle Review (LC02.06) 1871.06 II Herbst Jan 2009
Case Study: Management of Advanced NSCLCTx Reporter e-Newsletter (LC02.05) 1872.01 II Herbst
Langer
Govindan
Jan 2009
Expert Insight Into: Sublobar Resection for Patients with Peripheral Small Adenocarcinomas of the Lung: Surgical Outcome is Associated with Features on Computed Tomographic ImagingArticle Review (LC02.04) 1871.04 II Shrager Dec 2008
Expert Insight Into: The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer Article Review (LC02.03) 1871.03 II Shrager Nov 2008
Expert Insight Into: Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-€“Small-Cell Lung CancerArticle Review (LC02.02) 1871.02 II Langer Oct 2008
Expert Insight Into: New Guidelines in the Treatment of Non-€“Small-Cell Lung Cancer (NSCLC)Article Review (LC02.01) 1871.01 II Herbst Oct 2008
Combining EGFR and Antiangiogenic Agents in NSCLCArticle Review (LC01.24) 1794.12 I Herbst Mar 2008
Case Study: Choosing Specific Treatment Schedules and Agents in Locally Advanced Unresected NSCLCTx Reporter e-Newsletter (LC01.23) 1795.06 I Herbst
Choy
Sandler
Feb 2008
Molecular Analysis Can Improve Therapy Decisions for Advanced Non–Small-Cell Lung CancerArticle Review (LC01.22) 1794.11 I Brahmer Feb 2008
Case Study: Supportive Care of the Patient Undergoing Antineoplastic Treatment for NSCLCTx Reporter e-Newsletter (LC01.21) 1795.05 I Herbst
Langer
Jan 2008
The Role of Systemic Therapy in PS-2 Advanced NSCLCArticle Review (LC01.19) 1794.10 I Langer Jan 2008
Case Study: Management of Recurrent Metastatic NSCLC—Chronic Treatment with Biologic AgentsTx Reporter e-Newsletter (LC01.20) 1795.04 I Herbst
Langer
Jan 2008
Role of Small Molecule Multikinase Inhibitors in NSCLCArticle Review (LC01.18) 1794.09 I Sandler Dec 2007
Emerging Concepts and Controversies in Lung CancerAudio Interview (LC01.17) 1797.06 I Herbst
Brahmer
Dec 2007
Innovative Local Treatment StrategiesAudio Interview (LC01.16) 1797.05 I Langer
Choy
Pass
Dec 2007
Role of Prophylactic Cranial Irradiation in Preventing Brain Metastasis and Improving Overall Survival in Patients with Extensive Small-Cell Lung CancerArticle Review (LC01.15) 1794.08 I Choy Nov 2007
Case Study: Staging and Treatment Approaches in Advanced NSCLCTx Reporter e-Newsletter (LC01.13) 1795.03 I Langer
Brahmer
Oct 2007
Treatment of Advanced Bronchioloalveolar Carcinoma (BAC)Article Review (LC01.14) 1794.07 I Sandler Oct 2007
How to Best Integrate Chemotherapy with RT in Locally Advanced NSCLCArticle Review (LC01.12) 1794.06 I Herbst Sep 2007
What’s New in EGFR and Other Targeted Therapies in NSCLC?Audio Interview (LC01.11) 1797.04 I Langer
Sandler
Sep 2007
MET Amplification: A Mechanism Leading to Gefitinib Resistance in NSCLCArticle Review (LC01.10) 1794.05 I Herbst Aug 2007
Case Study: Clinical Staging, Initial Prognosticators, and Treatment Approaches in NSCLCTx Reporter e-Newsletter (LC01.09) 1795.02 I Herbst
Sandler
Pass
Aug 2007
Emerging Chemotherapies and Antiangiogenesis Therapies in NSCLCAudio Interview (LC01.08) 1797.03 I Herbst
Langer
Aug 2007
State-of-the-Art Mediastinal Staging with PETArticle Review (LC01.07) 1794.04 I Pass Jul 2007
Case Study: NSCLC Basics - €”Screening and DetectionTx Reporter e-Newsletter (LC01.05) 1795.01 I Langer
Pass
Jul 2007
Confirmation of the Role of Angiogenesis Inhibition in Advanced NSCLCArticle Review (LC01.06) 1794.03 I Sandler Jul 2007
Clinical Staging and Stage-Specific Treatment Approaches to Curable NSCLCAudio Interview (LC01.04) 1797.02 I Herbst
Choy
Pass
Jun 2007
The Seesaw Odyssey of Irinotecan in the Therapy of Small-Cell Lung CarcinomaArticle Review (LC01.03) 1794.02 I Langer May 2007
Applying Standard Guidelines to Practice Audio Interview (LC01.02) 1797.01 I Herbst
Langer
Apr 2007
What's New in State-of-the-Art Adjuvant Therapy in Resectable (I-IIIA) Lung Cancer?Article Review (LC01.01) 1794.01 I Brahmer Apr 2007







FIFA 14 Coins | WildStar Gold | WildStar Platinum | Fifa 14 Coins | Fifa Ultimate Team Coins | FIFA 14 Coins | Fut 14 Coins | Tattoo Supplies | Tattoo Kits | FIFA 14 Coins | Replica Handbags | Sexy Lingerie | FIFA 14 Coins | Wedding Dresses | Tattoo Supplies | Iphone 5s case | Wedding Dresses | Fashion Shoes | Wedding Dresses